Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Visualizing VEGF Producing Lesions in Von Hippel-Lindau Disease

Trial Profile

Visualizing VEGF Producing Lesions in Von Hippel-Lindau Disease

Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2018

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Haemangioblastoma; Neuroendocrine tumours; Pancreatic cancer; Phaeochromocytoma; Renal cell carcinoma; Von Hippel-Lindau disease
  • Focus Diagnostic use
  • Acronyms VHLimage
  • Most Recent Events

    • 18 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top